NCT05904613View on ClinicalTrials.gov

Evaluation of the Impact of the XEN® Implant on Endothelial Cell Density, 3 Years After Surgery

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

October 9, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Glaucoma
Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER

NCT05904613 - Evaluation of the Impact of the XEN® Implant on Endothelial Cell Density, 3 Years After Surgery | Biotech Hunter | Biotech Hunter